Correlation Between Oncternal Therapeutics and Virios Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oncternal Therapeutics and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncternal Therapeutics and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncternal Therapeutics and Virios Therapeutics Llc, you can compare the effects of market volatilities on Oncternal Therapeutics and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncternal Therapeutics with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncternal Therapeutics and Virios Therapeutics.
Diversification Opportunities for Oncternal Therapeutics and Virios Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Oncternal and Virios is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Oncternal Therapeutics and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and Oncternal Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncternal Therapeutics are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of Oncternal Therapeutics i.e., Oncternal Therapeutics and Virios Therapeutics go up and down completely randomly.
Pair Corralation between Oncternal Therapeutics and Virios Therapeutics
Given the investment horizon of 90 days Oncternal Therapeutics is expected to under-perform the Virios Therapeutics. In addition to that, Oncternal Therapeutics is 1.77 times more volatile than Virios Therapeutics Llc. It trades about -0.21 of its total potential returns per unit of risk. Virios Therapeutics Llc is currently generating about -0.06 per unit of volatility. If you would invest 27.00 in Virios Therapeutics Llc on June 24, 2024 and sell it today you would lose (7.00) from holding Virios Therapeutics Llc or give up 25.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Oncternal Therapeutics vs. Virios Therapeutics Llc
Performance |
Timeline |
Oncternal Therapeutics |
Virios Therapeutics Llc |
Oncternal Therapeutics and Virios Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncternal Therapeutics and Virios Therapeutics
The main advantage of trading using opposite Oncternal Therapeutics and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncternal Therapeutics position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.Oncternal Therapeutics vs. HCW Biologics | Oncternal Therapeutics vs. RenovoRx | Oncternal Therapeutics vs. Scpharmaceuticals | Oncternal Therapeutics vs. Milestone Pharmaceuticals |
Virios Therapeutics vs. HCW Biologics | Virios Therapeutics vs. RenovoRx | Virios Therapeutics vs. Scpharmaceuticals | Virios Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |